Latest Publications

Featured Article

Intern Med J. 2018

Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma

Trotman J, Cheah CY, Marlton P, Opat S

PDF Article

---

More Publications

• Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
  Source: Dr Gavin CullPublished on 2018-09-26
• Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.
  Source: Dr Julie CrawfordPublished on 2018-09-21
• Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.
  Source: Dr Julie CrawfordPublished on 2018-09-21
• Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients.
  Source: Dr Julie CrawfordPublished on 2018-09-21
• Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease.
  Source: Dr Julie CrawfordPublished on 2018-09-21
• Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
  Source: Dr Chan CheahPublished on 2018-09-20
• Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.
  Source: Dr Chan CheahPublished on 2018-07-11
• FDG-PET/CT in the management of lymphomas: Current status and future directions.
  Source: Dr Chan CheahPublished on 2018-07-11
• Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
  Source: Dr Chan CheahPublished on 2018-07-07
• Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement.
  Source: Dr Chan CheahPublished on 2018-04-21
• Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure.
  Source: Dr Dejan RadeskiPublished on 2018-04-20
• Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
  Source: Dr Dejan RadeskiPublished on 2018-04-20
• Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma.
  Source: Dr Dejan RadeskiPublished on 2018-04-20
• Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series.
  Source: Dr Dejan RadeskiPublished on 2018-04-20
• Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review.
  Source: Dr Dejan RadeskiPublished on 2018-04-20

Older posts